CHARACTERISTICS OF THE CONDITION OF CENTRAL RETINA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND PROLIFERATIVE DIABETIC RETINOPATHY (26-31)

Архив в PDF формате
Дата публикации статьи в журнале: 2020/01/08
Название журнала: Восточно Европейский Научный Журнал, Выпуск: 52, Том: 1, Страницы в выпуске: 26-31
Автор: Maksymtsiv M.L.
, Danylo Halytsky Lviv National Medical University,
Анотация: . Objective. To Investigate the characteristics of the condition of central retina in patients with type 2 diabetes mellitus (DM2) and proliferative diabetic retinopathy (PDR). The study involved 62 patients with DM2. All patients were diagnosed with non-proliferative (31 patients, 31 eyes) and proliferative diabetic retinopathy (31 patients, 31 eyes) on the basis of results of clinical and instrumental examination and according to the ETDRS classification. The ophthalmological examination included measurements of visual acuity with optimal optical correction, tonometry, biomicroscopy, ophthalmoscopy, optical coherence tomography. The thickness and volume of the central retina in patients with proliferative DR were 309.0 ± 130.0 μm and 7.6 ± 2.7 mm3, respectively, in subcompensated DM, whereas these indicators were 287.0 ± 40.0 μm and 7.80 ± 0.57 mm3 (p> 0.05), respectively, in decompensated DM. A statistically significant decrease in corrected visual acuity (p = 0.012) and an increase in the volume of the central retina (by 6.9%; p = 0.034) were detected under the conditions of diabetic retinopathy (DR) progression. More expressed demonstrative changes in the retina (p <0.05) were found in patients with proliferative DR complicated by macular edema. Patients with PDR had no differences in eye condition in subcompensation and decompensation of DM2. As a result of progression of DR from non-proliferative to proliferative stage, the corrected visual acuity decreased and the thickness and volume of central macular retina increased. This may be associated with the development of edema due to the progression of the pathological process.
Ключевые слова: proliferative diabetic retinopathy   type 2 diabetes mellitus   central retina   macula edema   retinal volume  
Данные для цитирования: Maksymtsiv M.L. , . CHARACTERISTICS OF THE CONDITION OF CENTRAL RETINA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND PROLIFERATIVE DIABETIC RETINOPATHY (26-31). Восточно Европейский Научный Журнал. Медицинские науки. 2020/01/08; 52(1):26-31.

Список литературы: 1. Kaminskiy OV. Official criteria for diagnostics of diabetes mellitus, normoglycemia and glycemic self-control. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2017;13(3):184-190. Doi: 10.22141/2224-0721.13.3.2017.104117. (in Ukrainian). 2. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. doi: 10.1186/s40662-015-0026-2. 3. Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob Health. 2013;1(6):e339-49. doi: 10.1016/S2214109X(13)70113-X. 4. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-64. doi: 10.2337/dc11-1909. 5. He F, Xia X, Wu XF, Yu XQ, Huang FX. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia. 2013;56(3):457-66. doi: 10.1007/s00125-012-2796-6. 6. Mottl AK, Pajewski N, Fonseca V, et al. The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial. J Diabetes Complications. 2014;28(6):874-9. doi: 10.1016/j.jdiacomp.2014.07.001. 7. Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015;99(1):64-8. doi: 10.1136/ bjophthalmol-2013-304017. 8. Azrak C, Baeza-Díaz MV, Palazón-Bru A, et al. Validity of Optical Coherence Tomography as a Diagnostic Method for Diabetic Retinopathy and Diabetic Macular Edema. Medicine (Baltimore). 2015;94(38):e1579. doi: 10.1097/ MD.0000000000001579. 9. Gozlan J, Ingrand P, Lichtwitz O. et al. Retinal microvascular alterations related to diabetes assessed by optical coherence tomographyangiography: A crosssectional analysis. Medicine (Baltimore). 2017;96(15):e6427. doi:10.1097/ MD.0000000000006427. 10. Bertelsen G, Peto T, Lindekleiv H, et al. Tromso eye study: prevalence and risk factors of diabetic retinopathy. Acta Ophthalmol. 2013;91(8):716-21. doi: 10.1111/j.17553768.2012.02542.x. 11. Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications. 2012;26(2):123-8. doi: 10.1016/j.jdia- comp.2012.02.001. 12. Broe R, Rasmussen ML, Frydkjaer-Olsen U, et al. The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetol. 2014;51(3):413-20. doi: 10.1007/ s00592-013-0527-1. 13. Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the diabetic retinopathy screening service for wales: retrospective analysis. BMJ. 2012;344:e874. doi: 10.1136/bmj.e874. 14. Jones CD, Greenwood RH, Misra A, Bachmann MO. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35(3):592-6. doi: 10.2337/dc11-0943. 15. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346-54. doi: 10.1007/s11892012-0283-6.